Pain Management for Systemic Lupus Erythematosus (SLE)

First-Line Approaches

The European League Against Rheumatism recommends antimalarials (primarily hydroxychloroquine) as the foundation of treatment for SLE patients, unless contraindicated, to manage underlying disease activity that contributes to pain 3
The American College of Rheumatology suggests NSAIDs as first-line drug treatment for patients with pain and stiffness, particularly for musculoskeletal manifestations 4
For patients with increased gastrointestinal risk, the European League Against Rheumatism recommends considering either non-selective NSAIDs plus a gastroprotective agent (PPI or misoprostol) or a selective COX-2 inhibitor 4

The American College of Rheumatology recommends analgesics such as acetaminophen (paracetamol) and opioids for pain control when NSAIDs are insufficient, contraindicated, or poorly tolerated 4, 3
The European League Against Rheumatism suggests corticosteroids at the lowest possible dose and for the shortest duration for acute pain flares 1, 2
Local corticosteroid injections directed to specific sites of musculoskeletal inflammation may be beneficial, according to the American College of Rheumatology 4

The American College of Rheumatology recommends patient education about the disease and pain management strategies 4, 3
Regular exercise tailored to the patient's capabilities is suggested by the European League Against Rheumatism 4
Physical therapy (individual or group) and psychological support for pain coping strategies are recommended by the American College of Rheumatology 4, 3

In patients with antiphospholipid antibodies, low-dose aspirin may provide dual benefits for pain and thrombosis prevention, according to the American College of Rheumatology 3
During pregnancy, the European League Against Rheumatism recommends using prednisolone, azathioprine, hydroxychloroquine, and low-dose aspirin, while avoiding mycophenolate mofetil, cyclophosphamide, and methotrexate 3
For neuropsychiatric lupus with pain manifestations, immunosuppressive therapy with cyclophosphamide may be beneficial, according to the American College of Rheumatology 5

Prolonged use of high-dose glucocorticoids (>7.5 mg/day prednisone equivalent) increases risk of irreversible organ damage, warns the American College of Rheumatology 6
Always assess medication adherence, especially to hydroxychloroquine, as non-adherence is associated with higher flare rates and increased pain, according to the European League Against Rheumatism 6
Regular monitoring of disease activity is essential to distinguish between pain due to active inflammation versus damage or fibromyalgia, recommends the American College of Rheumatology 3